Shopping Cart 0
Cart Subtotal
USD 0

China Cardiac Rhythm Management Devices Market Outlook to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985

Details

China Cardiac Rhythm Management Devices Market Outlook to 2025

Summary

GlobalData's new report, "China Cardiac Rhythm Management Devices Market Outlook to 2025", provides key market data on the China Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Cardiac Rhythm Management Devices market segments-Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

2017 company share and distribution share data for Cardiac Rhythm Management Devices market.

Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices market.

Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Cardiac Rhythm Management Devices Segmentation

2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, China

3.1 Cardiac Rhythm Management Devices Market, China, Revenue (USDm), 2015-2025

3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), by Segment, 2015-2025

3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), by Segment, 2015-2025

3.1.3 Pacemakers Market, China, Revenue (USDm), by Segment, 2015-2025

3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025

3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2015-2025

3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2015-2025

3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2015-2025

3.3 Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2015-2025

3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue (USDm), 2017

3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue (USDm), 2017

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market

4.1 Medtronic Plc

4.1.1 Company Overview

4.2 Abbott Laboratories

4.2.1 Company Overview

4.3 Boston Scientific Corp

4.3.1 Company Overview

4.4 Biotronik AG

4.4.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Recent Developments

6.1 Corporate Communications

6.1.1 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

6.1.2 Sep 18, 2017: Concord Medical Announces Changes to the Board

6.1.3 Jul 24, 2017: Concord Medical Announces Changes to the Board

6.1.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board

6.2 Financial Announcements

6.2.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY

6.2.2 Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017

6.2.3 Aug 15, 2017: CareRay Exhibits At FIME 2017

6.2.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%

6.2.5 Mar 30, 2017: MPSC Announces 2016 Annual Results

6.3 Other Significant Developments

6.3.1 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center

6.4 Product News

6.4.1 Dec 18, 2017: The CFDA Approves Impulse Dynamics' Optimizer System for Treatment of Chronic Heart Failure in China

6.4.2 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017

6.5 Strategy And Business Planning

6.5.1 Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital

7 Appendix

7.1 Research Methodology

7.1.1 Coverage

7.1.2 Secondary Research

7.1.3 Primary Research

7.1.4 Market Modeling and Forecasting

7.1.5 Company Share Analysis

7.1.6 Distribution Share Analysis

7.1.7 Benchmarking

7.2 GlobalData Consulting

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 4: Pacemakers Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025

Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2025

Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2025

Figure 8: Pacemakers Market, China, Volume (Units), 2015-2025

Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2017


List Of Table

1.1 List of Tables

Table 1: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 2: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 3: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 4: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 5: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 6: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 7: Pacemakers Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 8: Pacemakers Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 9: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2020

Table 10: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2021-2025

Table 11: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2020

Table 12: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2021-2025

Table 13: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2020

Table 14: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2021-2025

Table 15: Pacemakers Market, China, Volume (Units), 2015-2020

Table 16: Pacemakers Market, China, Volume (Units), 2021-2025

Table 17: Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2015-2020

Table 18: Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2021-2025

Table 19: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue (USDm), USD Constant, 2017

Table 20: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue (USDm), USD Constant, 2017

Table 21: Cardiac Rhythm Management Devices Market Pipeline Products

Table 22: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Medtronic Plc

Abbott Laboratories

Boston Scientific Corp

Biotronik AG

China Cardiac Rhythm Management Devices Market Outlook to 2025

Summary

GlobalData's new report, "China Cardiac Rhythm Management Devices Market Outlook to 2025", provides key market data on the China Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Cardiac Rhythm Management Devices market segments-Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

2017 company share and distribution share data for Cardiac Rhythm Management Devices market.

Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices market.

Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Cardiac Rhythm Management Devices Segmentation

2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, China

3.1 Cardiac Rhythm Management Devices Market, China, Revenue (USDm), 2015-2025

3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), by Segment, 2015-2025

3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), by Segment, 2015-2025

3.1.3 Pacemakers Market, China, Revenue (USDm), by Segment, 2015-2025

3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025

3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2015-2025

3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2015-2025

3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2015-2025

3.3 Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2015-2025

3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue (USDm), 2017

3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue (USDm), 2017

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market

4.1 Medtronic Plc

4.1.1 Company Overview

4.2 Abbott Laboratories

4.2.1 Company Overview

4.3 Boston Scientific Corp

4.3.1 Company Overview

4.4 Biotronik AG

4.4.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Recent Developments

6.1 Corporate Communications

6.1.1 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

6.1.2 Sep 18, 2017: Concord Medical Announces Changes to the Board

6.1.3 Jul 24, 2017: Concord Medical Announces Changes to the Board

6.1.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board

6.2 Financial Announcements

6.2.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY

6.2.2 Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017

6.2.3 Aug 15, 2017: CareRay Exhibits At FIME 2017

6.2.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%

6.2.5 Mar 30, 2017: MPSC Announces 2016 Annual Results

6.3 Other Significant Developments

6.3.1 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center

6.4 Product News

6.4.1 Dec 18, 2017: The CFDA Approves Impulse Dynamics' Optimizer System for Treatment of Chronic Heart Failure in China

6.4.2 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017

6.5 Strategy And Business Planning

6.5.1 Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital

7 Appendix

7.1 Research Methodology

7.1.1 Coverage

7.1.2 Secondary Research

7.1.3 Primary Research

7.1.4 Market Modeling and Forecasting

7.1.5 Company Share Analysis

7.1.6 Distribution Share Analysis

7.1.7 Benchmarking

7.2 GlobalData Consulting

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 4: Pacemakers Market, China, Revenue (USDm), USD Constant, 2015-2025

Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025

Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2025

Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2025

Figure 8: Pacemakers Market, China, Volume (Units), 2015-2025

Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2017


List Of Table

1.1 List of Tables

Table 1: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 2: Cardiac Rhythm Management Devices Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 3: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 4: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 5: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 6: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 7: Pacemakers Market, China, Revenue (USDm), USD Constant, 2015-2020

Table 8: Pacemakers Market, China, Revenue (USDm), USD Constant, 2021-2025

Table 9: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2020

Table 10: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2021-2025

Table 11: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2020

Table 12: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2021-2025

Table 13: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2020

Table 14: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2021-2025

Table 15: Pacemakers Market, China, Volume (Units), 2015-2020

Table 16: Pacemakers Market, China, Volume (Units), 2021-2025

Table 17: Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2015-2020

Table 18: Cardiac Rhythm Management Devices Market, China, Average Price (USD), 2021-2025

Table 19: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue (USDm), USD Constant, 2017

Table 20: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue (USDm), USD Constant, 2017

Table 21: Cardiac Rhythm Management Devices Market Pipeline Products

Table 22: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Medtronic Plc

Abbott Laboratories

Boston Scientific Corp

Biotronik AG